ArticleNeuro-oncology2023

Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, "window-of-opportunity" study.

Victor Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.